Delayed Cord Clamping with Oxygen for Premature Birth (DOXIE Trial)
Trial Summary
The trial information does not specify whether participants need to stop taking their current medications.
Research suggests that physiological-based cord clamping (PBCC), which is part of the treatment, helps stabilize blood flow and improve outcomes in very preterm infants by allowing better lung and heart function. Additionally, delayed umbilical cord clamping is known to increase blood volume in newborns, which can be beneficial for premature babies.
12345The research on delayed cord clamping (DCC) in preterm infants suggests it is generally safe, as it does not increase the need for inotropic support (medications that help the heart pump blood) or affect mean arterial blood pressure (average blood pressure in the arteries).
678910Delayed cord clamping with oxygen for premature birth is unique because it involves waiting to clamp the umbilical cord until the baby's lungs are working properly, which helps stabilize blood flow and reduce potential brain injury. This approach, known as physiological-based cord clamping (PBCC), contrasts with immediate cord clamping and aims to improve the baby's transition to life outside the womb.
1251112Eligibility Criteria
This trial is for preterm infants born up to 28+6 weeks gestational age, from any type of delivery and pregnancy. It's not for those with early membrane rupture before 20 weeks, congenital anomalies, fetal/maternal compromise, or if parents decline consent or resuscitation.Inclusion Criteria
Exclusion Criteria
Participant Groups
- Preterm infants for improved transitional circulation, better establishment of red blood cell volume, decreased need for blood transfusion, and lower incidence of necrotizing enterocolitis and intraventricular hemorrhage
- Term and preterm infants for improved hemoglobin levels, iron stores, and developmental outcomes, and reduced risk of intraventricular hemorrhage and necrotizing enterocolitis